Quantifying the performance of in vivo portal dosimetry in detecting four types of treatment parameter variations

Medical Physics

Volumn 42, Issue 12, 2015, Pages 6912-6918

  Bojechko, C ^a   Ford, E C ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

EPID; error detection; in vivo dosimetry; patient safety; quality assurance

Indexed keywords

DOSIMETRY; PHANTOMS; RADIOTHERAPY; SOFTWARE PROTOTYPING;

AREA UNDER THE ROC CURVE; DETECTABILITY; ELECTRONIC PORTAL IMAGING DEVICES; IN-VIVO; IN-VIVO DOSIMETRY; MULTILEAF COLLIMATORS; PARAMETERS VARIATIONS; PATIENT SAFETY; TREATMENT PLANNING SYSTEMS; VIVO DOSIMETRY;

QUALITY ASSURANCE;

ALGORITHM; ARTICLE; BODY BUILD; CHANGES IN THE PATIENT BODY CONTOUR; CLINICAL ARTICLE; COMPUTER PROGRAM; DOSIMETRY; ELECTRONIC PORTAL IMAGING DEVICE; HISTOGRAM; HUMAN; IN VIVO PORTAL DOSIMETRY; INTENSITY MODULATED RADIATION THERAPY; MULTILEAF COLLIMATOR; OVERALL DOSE SCALING; PATIENT POSITIONING; QUALITY CONTROL; RADIATION DOSE; RADIOLOGICAL PARAMETERS; RADIOTHERAPY PLANNING SYSTEM; SHIFTING OF THE PATIENT POSITION; SHIFTING THE POSITIONS OF THE MULTILEAF COLLIMATOR LEAF; AREA UNDER THE CURVE; COMPUTER SIMULATION; DEVICES; INFORMATION PROCESSING; PROCEDURES; RADIOMETRY; RADIOTHERAPY DOSAGE; RECEIVER OPERATING CHARACTERISTIC;

AREA UNDER CURVE; COMPUTER SIMULATION; DATASETS AS TOPIC; HUMANS; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; ROC CURVE;

EID: 84947474571     PISSN: 00942405     EISSN: 24734209     Source Type: Journal    
DOI: 10.1118/1.4935093     Document Type: Article

References (36)

1. G. A. Ezzell, J. M. Galvin, D. Low, J. R. Palta, I. Rosen, M. B. Sharpe, P. Xia, Y. Xiao, L. Xing, and C. X. Yu, " Guidance document on delivery, treatment planning, and clinical implementation of IMRT: Report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee," Med. Phys. 30, 2089-2115 (2003). 10.1118/1.1591194
2. A. Mans, M. Wendling, L. N. McDermott, J. J. Sonke, R. Tielenburg, R. Vijlbrief, B. Mijnheer, M. van Herk, and J. C. Stroom, " Catching errors with in vivo EPID dosimetry," Med. Phys. 37, 2638-2644 (2010). 10.1118/1.3397807
3. G. J. Kutcher et al., " Comprehensive QA for radiation oncology: Report of AAPM Radiation Therapy Committee Task Group 40," Med. Phys. 21, 581-618 (1994). 10.1118/1.597316
4. International Atomic Energy Agency, International Basic Safety Standards for Protection Against Ionizing Radiation and for the Safety of Radiation Sources (IAEA, Vienna, Austria, 2014).
5. J. Van Dam and G. Marinello, " Methods for in vivo dosimetry in external radiotherapy," in Physics for Clinical Radiotherapy, ESTRO Booklet No. 1 (ESTRO, Brussels, Belgium, 1994).
6. International Atomic Energy Agency, " Development of procedures for in vivo dosimetry in radiotherapy," IAEA Human Health Report No. 8, 2013.
7. Report of Task Group 62 of the Radiation Therapy Committee, " Diode in vivo dosimetry for patients receiving external beam radiation therapy," AAPM Report No. 87, 2005.
8. W. van Elmpt, L. McDermott, S. Nijsten, M. Wendling, P. Lambin, and B. Mijnheer, " A literature review of electronic portal imaging for radiotherapy dosimetry," Radiother. Oncol. 88, 289-309 (2008). 10.1016/j.radonc.2008.07.008
9. M. Hussein, P. Rowshanfarzad, M. A. Ebert, A. Nisbet, and C. H. Clark, " A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems," Radiother. Oncol. 109, 370-376 (2013). 10.1016/j.radonc.2013.08.048
10. P. Rowshanfarzad, M. Sabet, M. P. Barnes, D. J. O'Connor, and P. B. Greer, " EPID-based verification of the MLC performance for dynamic IMRT and VMAT," Med. Phys. 39, 6192-6207 (2012). 10.1118/1.4752207
11. J. J. Gordon, J. K. Gardner, S. Wang, and J. V. Siebers, " Reliable detection of fluence anomalies in EPID-based IMRT pretreatment quality assurance using pixel intensity deviations," Med. Phys. 39, 4959-4975 (2012). 10.1118/1.4736821
12. J. J. Kruse, " On the insensitivity of single field planar dosimetry to IMRT inaccuracies," Med. Phys. 37, 2516-2524 (2010). 10.1118/1.3425781
13. Y. L. Kim, J. B. Chung, J. S. Kim, J. W. Lee, and K. S. Choi, " Comparison of the performance between portal dosimetry and a commercial two-dimensional array system on pretreatment quality assurance for volumetric-modulated arc and intensity-modulated radiation therapy," J. Korean Phys. Soc. 64, 1207-1212 (2014). 10.3938/jkps.64.1207
14. A. Rangel, G. Palte, and P. Dunscombe, " The sensitivity of patient specific IMRT QC to systematic MLC leaf bank offset errors," Med. Phys. 37, 3862-3867 (2010). 10.1118/1.3453576
15. L. N. McDermott, M. Wendling, J. J. Sonke, M. van Herk, and B. J. Mijnheer, " Replacing pretreatment verification with in vivo EPID dosimetry for prostate IMRT," Int. J. Radiat. Oncol., Biol., Phys. 67, 1568-1577 (2007). 10.1016/j.ijrobp.2006.11.047
16. L. N. McDermott, M. Wendling, B. van Asselen, J. Stroom, J. J. Sonke, M. van Herk, and B. J. Mijnheer, " Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification," Med. Phys. 33, 3921-3930 (2006). 10.1118/1.2230810
17. M. Wendling, R. J. Louwe, L. N. McDermott, J. J. Sonke, M. van Herk, and B. J. Mijnheer, " Accurate two-dimensional IMRT verification using a back-projection EPID dosimetry method," Med. Phys. 33, 259-273 (2006). 10.1118/1.2147744
18. M. Wendling, L. N. McDermott, A. Mans, I. Olaciregui-Ruiz, R. Pecharroman-Gallego, J. J. Sonke, J. Stroom, M. van Herk, and B. J. Mijnheer, " In aqua vivo EPID dosimetry," Med. Phys. 39, 367-377 (2012). 10.1118/1.3665709
19. L. C. Persoon, S. M. Nijsten, F. J. Wilbrink, M. Podesta, J. A. Snaith, T. Lustberg, W. J. van Elmpt, F. van Gils, and F. Verhaegen, " Interfractional trend analysis of dose differences based on 2D transit portal dosimetry," Phys. Med. Biol. 57, 6445-6458 (2012). 10.1088/0031-9155/57/20/6445
20. L. C. Persoon, A. G. Egelmeer, M. C. Ollers, S. M. Nijsten, E. G. Troost, and F. Verhaegen, " First clinical results of adaptive radiotherapy based on 3D portal dosimetry for lung cancer patients with atelectasis treated with volumetric-modulated arc therapy (VMAT)," Acta Oncol. 52, 1484-1489 (2013). 10.3109/0284186X.2013.813642
21. I. Olaciregui-Ruiz, R. Rozendaal, B. Mijnheer, M. van Herk, and A. Mans, " Automatic in vivo portal dosimetry of all treatments," Phys. Med. Biol. 58, 8253-8264 (2013). 10.1088/0031-9155/58/22/8253
22. E. C. Ford, S. Terezakis, A. Souranis, K. Harris, H. Gay, and S. Mutic, " Quality control quantification (QCQ): A tool to measure the value of quality control checks in radiation oncology," Int. J. Radiat. Oncol., Biol., Phys. 84, e263-e269 (2012). 10.1016/j.ijrobp.2012.04.036
23. C. Bojechko, A. Kalet, M. H. Phillps, and E. C. Ford, " A quantification of the effectiveness of EPID dosimetry and software-based plan verification systems in detecting incidents in radiotherapy," Med. Phys. 42, 5363-5369 (2015). 10.1118/1.4928601
24. M. Carlone, C. Cruje, A. Rangel, R. McCabe, M. Nielsen, and M. Macpherson, " ROC analysis in patient specific quality assurance," Med. Phys. 40, 042103 (7pp.) (2013). 10.1118/1.4795757
25. P. Munro and D. C. Bouius, " X-ray quantum limited portal imaging using amorphous silicon flat-panel arrays," Med. Phys. 25, 689-702 (1998). 10.1118/1.598252
26. Y. El-Mohri, L. E. Antonuk, J. Yorkston, K. W. Jee, M. Maolinbay, K. L. Lam, and J. H. Siewerdsen, " Relative dosimetry using active matrix flat-panel imager (AMFPI) technology," Med. Phys. 26, 1530-1541 (1999). 10.1118/1.598649
27. B. M. C. McCurdy, K. B. Luchka, and S. Pistorius, " Dosimetric investigation and portal dose image prediction using an amorphous silicon electronic portal imaging device," Med. Phys. 28, 911-924 (2001). 10.1118/1.1374244
28. L. N. McDermott, R. J. Louwe, J. J. Sonke, M. B. van Herk, and B. J. Mijnheer, " Dose-response and ghosting effects of an amorphous silicon electronic portal imaging device," Med. Phys. 31, 285-295 (2004). 10.1118/1.1637969
29. M. Wendling, L. N. McDermott, A. Mans, J. J. Sonke, M. van Herk, and B. J. Mijnheer, " A simple backprojection algorithm for 3D in vivo EPID dosimetry of IMRT treatments," Med. Phys. 36, 3310-3321 (2009). 10.1118/1.3148482
30. D. A. Low, W. B. Harms, S. Mutic, and J. A. Purdy, " A technique for the quantitative evaluation of dose distributions," Med. Phys. 25, 656-661 (1998). 10.1118/1.598248
31. K. Pulliam, J. Kerns, R. M. Howell, D. S. Followill, J. O'Daniel, and S. F. Kry, " A survey of IMRT QA practices for more than 800 institutions," Med. Phys. 41, 432 (2014). 10.1118/1.4889185
32. E. M. McKenzie, P. A. Balter, F. C. Stingo, J. Jones, D. S. Followill, and S. F. Kry, " Toward optimizing patient-specific IMRT QA techniques in the accurate detection of dosimetrically acceptable and unacceptable patient plans," Med. Phys. 41, 121702 (15pp.) (2014). 10.1118/1.4899177
33. N. A. Obuchowski, " ROC analysis," AJR, Am. J. Roentgenol. 184, 364-372 (2005). 10.2214/ajr.184.2.01840364
34. S. Dische, M. I. Saunders, C. Williams, A. Hopkins, and E. Aird, " Precision in reporting the dose given in a course of radiotherapy," Radiother. Oncol. 29, 287-293 (1993). 10.1016/0167-8140(93)90146-Y
35. J. L. Bedford, I. M. Hanson, and V. N. Hansen, " Portal dosimetry for VMAT using integrated images obtained during treatment," Med. Phys. 41, 021725 (14pp.) (2014). 10.1118/1.4862515
36. B. E. Nelms, H. Zhen, and W. A. Tome, " Per-beam, planar IMRT QA passing rates do not predict clinically relevant patient dose errors," Med. Phys. 38, 1037-1044 (2011). 10.1118/1.3544657